Missouri's Fentanyl Problem: The China Connection.

Recently, Missouri has followed an overall upward trend in opioid overdose deaths. In 2018, Missouri was the state with the largest absolute and percentage increase in opioid-related overdose fatality rates per capita over the previous year (18.3% and 3.1/100,000). This increase occurred despite an overall decrease in U.S. opioid-related death rates in the same period. This report identifies illicitly manufactured fentanyl (IMF) (and analogues) as the drug most responsible for this rise in opioid deaths in Missouri, with stimulant overdoses (primarily from methamphetamine) in second place. Within Missouri, we find the areas where opioid deaths are highest: St. Louis and the city's fringe areas, following the national trend for high rates in fringe areas. Based on reports from CDC Wonder data, county medical examiners, law enforcement agencies, and drug addiction prevention agencies, we conclude that IMF and related synthetic opioids arriving from China are primarily responsible for fatal narcotic overdoses in Missouri. Despite the COVID-19 disruption of fentanyl manufacturing and distribution centers in and around Wuhan, China early in the pandemic, preliminary 2020 data from medical examiners' offices show an upswing in opioid deaths, an indicator that Chinese fentanyl producers have restored the supply chain.

[1]  P. Seth,et al.  Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018 , 2020, MMWR. Morbidity and mortality weekly report.

[2]  D. Fomin,et al.  Human deaths from drug overdoses with carfentanyl involvement—new rising problem in forensic medicine , 2018, Medicine.

[3]  B. Logan,et al.  Analysis of Fentanyl and 18 Novel Fentanyl Analogs and Metabolites by LC-MS-MS, and report of Fatalities Associated with Methoxyacetylfentanyl and Cyclopropylfentanyl. , 2018, Journal of analytical toxicology.

[4]  Bethany J Figg,et al.  Substance Abuse and Mental Health Services Administration , 2018, Journal of Consumer Health on the Internet.

[5]  M. Mignone,et al.  Life (and death) in Pink: The dangerous rise of synthetic opioids in the new psychoactive substances panorama , 2018, European Neuropsychopharmacology.

[6]  R. Pacifici,et al.  Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update , 2017, Therapeutic drug monitoring.

[7]  Likang Xu,et al.  Annual surveillance report of drug-related risks and outcomes -- United States, 2017 , 2017 .

[8]  Daniel Ciccarone,et al.  Fentanyl in the US heroin supply: A rapidly changing risk environment. , 2017, The International journal on drug policy.

[9]  J. Zawilska An Expanding World of Novel Psychoactive Substances: Opioids , 2017, Front. Psychiatry.

[10]  P. Mansky,et al.  Misuse of Novel Synthetic Opioids: A Deadly New Trend , 2017, Journal of addiction medicine.

[11]  P. Bourgois,et al.  The Textures of Heroin: User Perspectives on “Black Tar” and Powder Heroin in Two U.S. Cities , 2016, Journal of psychoactive drugs.

[12]  D. Kalb,et al.  MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES MISSOURI COMMUNITY-BASED HOME VISITING , 2013 .

[13]  C. Niemegeers,et al.  N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin. , 1976, Arzneimittel-Forschung.

[14]  P. Rhodes Administration. , 1933, Teachers College Record: The Voice of Scholarship in Education.